Novartis has announced that its Phase III PSMAddition trial of Pluvicto™ in combination with standard of care (SoC) has met its primary endpoin ...

Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in ...

Airbus has completed the first set of wings for the A350 freighter (A350F) at its Broughton site, marking a significant milestone in the developm ...

Germany’s small and medium-sized enterprises (SMEs) have significantly reduced their international business activities, with the number of busi ...

DHL will implement moderate price increases for international parcels and small packages starting July 1, 2025. The price adjustments will vary a ...

The merger of Vodafone UK and Three UK has officially concluded, creating VodafoneThree. This new venture will focus on deploying one of Europe’s most advanced 5G networks, with £11 billion earmarked ...

Kentaro Koyama, Chief Economist for Japan at Deutsche Securities, has been awarded the 2024 Forecast Accuracy Award for Japan by Consensus Econom ...

Siemens and Hirano Tecseed have partnered to advance battery manufacturing processes, focusing on digitalization and the optimization of coating ...

Deutsche Telekom's new campaign, "Open Your Eyes!", highlights the urgent need for more solidarity and civil courage in the face of growing hate ...

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

BILD and ROCK AM RING team up for the festival’s 40th anniversary, providing an exclusive livestream of the Utopia Stage and editorial coverage ...

Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing o ...